Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant.
This case report describes the successful treatment of severe plaque psoriasis with etanercept in a patient who underwent a liver transplant. It also addresses the concerns that arise in the treatment of chronic inflammatory dermatologic disease accompanied by multiple organ disorders.
Hoover
William David
WD
chiph@vnet.net
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D000068800:Etanercept; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000150:complications; D020123:Sirolimus / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept; D020123:Sirolimus; D016559:Tacrolimus